Delivery Order SPE2DB22D2211-SPE2DB25FSDAN
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10mg tablets in a quantity of 100 units, with a contract ceiling value of $3,111.86. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 100 tablets of Clobazam 10 mg at a ceiling value of $6,303.15. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $7,435.86 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Clobazam 10 mg tablets (100-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count) valued at $1,555.93 under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10 mg tablets in a quantity of 100 units, with a ceiling value of $7,124.30. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,626.48 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $3,191.96 delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100s) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order, with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for supply of Clobazam 10 mg tablets in a quantity of 100 units, valued at $1,555.93. The award, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of August 13, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is located...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDANDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $4,491.92. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion on August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Clobazam is an anti-seizure medication used in neurological treatment protocols, consistent with AmerisourceBergen's established role as a critical pharmaceutical supplier to the Defense Health Agency and military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's federal contract awards demonstrate its consistent capability to fulfill competitive procurement requirements across the DLA's Medical Supply Chain, supporting military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/18/25 |